Zurueck zur Suche

Reporte zur Charge 4N2EZ

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MT 2

VAERS 2643210

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 4N2EZ

gering
Staat
MT
Alter
10,0
Geschlecht
M
Eingang
09.06.2023
Impfdatum
06.06.2023
Beginn
06.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Boostrix + Administration of expired dose.; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 10-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 4N2EZ, expiry date 03-JUN-2023) for prophylaxis. On 06-JUN-2023, the patient received Boostrix. On 06-JUN-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Boostrix + Administration of expired dose). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 7-Jun-2023 The nurse asked that the dose was valid. The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow-up. The patient received an expired dose of Boostrix, which led to expired vaccine used. The case was linked with case US2023080436, reported by same reporter for different patient.; Sender's Comments: US-GSK-US2023080436:same reporter, different patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2643094

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 4N2EZ

gering
Staat
MT
Alter
12,0
Geschlecht
F
Eingang
08.06.2023
Impfdatum
06.06.2023
Beginn
06.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

2 patients received a dose of Boostrix that expired on June 3rd 2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 12-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 4N2EZ, expiry date 03-JUN-2023) for prophylaxis. On 06-JUN-2023, the patient received Boostrix. On 06-JUN-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: 2 patients received a dose of Boostrix that expired on June 3rd 2023). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-JUN-2023 The reporter wanted to know if the dose was valid. The Vaccine Administration Facility is the same as Primary Reporter. The reporter did not consent to follow-up. The patient received a dose of Boostrix that expired, which led to expired vaccine used. This was 1 of 2 cases, reported by the same reporter.; Sender's Comments: US-GSK-US2023080435:same reporter, different patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-